Imperial’s US hub launches with AI and robotics leaders in San Francisco
Stent surgery and quantum entanglement: News from Imperial
Two new research units to protect public health and respond to major threats
Project title: Development of non-invasive deep brain stimulation technology Supervisor: Dr Nir Grossman
Project Title: Investigating the interplay between circadian clocks and mTOR signalling in microglia and its disruption in neurodegeneration. Supervisor: Dr Marco Brancaccio
Project Title: Investigation of stress-induced senescence associated with ageing and neurodegeneration Supervisor: Dr Raffaella Nativio and Professor Jesus Gil
Project title: Development of metabolic profiling pipelines for characterising cognitive processes Supervisors: Professor Elaine Holmes, Professor Bill Wisden and Prof Julian Griffin
Project Title: Characterisation of Glial & Neuronal Pathology Associated with Aβ Proteins in an Alzheimer’s Disease Model Supervisor: Prof. Paul Matthews and Prof. Steve Gentleman
Project title: Closed-loop, personalized brain stimulation intervention for impairment of cognitive control Supervisor: Dr Nir Grossman
Project title: Investigating Homeostatic Plasticity in Alzheimer’s Disease Supervisor: Dr Sam Barnes
Project Title: Elucidating Genetic Regulatory Networks in Alzheimer’s Disease with Drug Repurposing Supervisor: Professor Paul Matthews and Dr Eugene Duff
Project Title: Functional and molecular signatures of synaptic vulnerability in early Alzheimer’s Disease Supervisors: Dr Samuel Barnes and Dr Johanna Jackson
Project title: Non-invasive closed-loop neuromodulation for restorative sleep in neurodegenerative diseases Supervisor: Dr Nir Grossman
Project title: Development of non-invasive deep brain stimulation technology for neuroscience research and therapy Supervisor: Dr Nir Grossman
Project title: Non-invasive focused stimulation of neural activity Supervisor: Dr Nir Grossman
Project title: Non-invasive deep brain stimulation to modulate brain activity and related function Supervisor: Dr Nir Grossman
Project title: Predicting the epigenomic and clinical phenotypic effects of genomic mutations through deep learning Supervisor: Dr Nathan Skene
Project title: Post-translational modifications of amyloid proteins for proteasomal degradation Supervisor: Dr Yu Ye
Project Title: Spatially resolved transcriptome profiling in post-mortem human brains of Alzheimer’s disease Supervisor: Professor Paul Matthews
Project title: Elucidation of epigenetic mechanisms involved in Parkinson’s Disease Supervisor: Dr Sarah Marzi, Professor Paul Matthews
Project Title: Investigation of the role of astrocytes in encoding circadian function and their mis-regulation in Alzheimer’s disease Supervisor: Dr Marco Brancaccio
Project title: Genetic identification of cell types underlying brain disorders using single nucleus ATAC-seq data Supervisor: Dr Nathan Skene
Project Title: Identification of cell types underlying genomic evolution in primates and how this relates to genetic risk for brain disorders Supervisors: Dr Nathan Skene, Professor Steve Gentleman, Dr Sarah Marzi
Project Title: The role of genetic risk variants in regulatory elements in Parkinson’s Disease Supervisor: Dr Alexi Nott
Project Title: Immunoproteasomes in tauopathies Supervisors: Dr Yu Ye, Dr Johanna Jackson
Project Title: Exploration of enhancer landscapes in Alzheimer’s disease (AD) patients with the aim to reveal signalling pathways associated with the disease pathogenesis Supervisor: Dr Alexi Nott
Project Title: Multi-omics analyses for human Alzheimer’s disease research Supervisor: Dr. Nurun Fancy, Dr. Johanna Jackson, Professor Paul M Matthews
Project Title: Prediction of cell-type specific effects of genetic variants in Alzheimer's disease. Supervisor: Dr Nathan Skene
Project title: Proteomic signatures of synaptic vulnerability and resilience in Alzheimer’s Disease Supervisor: Dr Samuel Barnes
Find out more about Imperial funding schemes and external funding opportunities for PhD students on our Training page
